Clinical-grade at-home Wesper offers a clinical-grade, FDA-cleared wireless home sleep testing platform, enabling sales conversations with healthcare providers seeking scalable, patient-friendly sleep diagnostics and monitoring outside traditional labs.

Multi-tier ecosystem Recent launches of Wesper Lite and a multi-tier sleep diagnostic ecosystem signal expansion into varied diagnostic needs, creating cross-sell opportunities with clinics and payers seeking tiered solutions and personalized sleep care pathways.

Remote patient monitoring Integrated remote patient monitoring and mobile app engagement present a compelling value prop for hospitals, sleep centers, and ENT/primary care partners aiming to improve adherence, data capture, and outcomes in sleep therapy.

Strategic funding momentum Previous Series A funding and ongoing growth indicate investor confidence and a runway for scale, making it a favorable context for partnerships, channel deals, and joint ventures with distributors in the wellness and clinical tech space.

Market expansion readiness Wesper’s positioning around at-home testing, high correlation with sleep labs, and a growing product suite align with market trends toward home-based diagnostics, telehealth integration, and personalized sleep care—ideal for enterprise sales to health systems and specialty clinics.